Morgan Stanley (MS) concluded trading on Thursday at a closing price of $134.34, with 8.86 million shares of worth about $1.19 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 32.03% during that period and on February 20, 2025 the price saw a loss of about -4.51%. Currently the company’s common shares owned by public are about 1.61B shares, out of which, 1.23B shares are available for trading.
Stock saw a price change of -2.02% in past 5 days and over the past one month there was a price change of -2.16%. Year-to-date (YTD), MS shares are showing a performance of 6.86% which increased to 55.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $84.43 but also hit the highest price of $142.03 during that period. The average intraday trading volume for Morgan Stanley shares is 6.24 million. The stock is currently trading -2.85% below its 20-day simple moving average (SMA20), while that difference is up 1.82% for SMA50 and it goes to 19.00% higher than SMA200.
Morgan Stanley (NYSE: MS) currently have 1.61B outstanding shares and institutions hold larger chunk of about 61.77% of that.
The stock has a current market capitalization of $216.43B and its 3Y-monthly beta is at 1.34. PE ratio of stock for trailing 12 months is 16.90, while it has posted earnings per share of $7.95 in the same period. Its PEG reads 1.72 while making debt-to-equity ratio of 2.93. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MS, volatility over the week remained 2.53% while standing at 2.04% over the month.
Stock’s fiscal year EPS is expected to rise by 9.35% while it is estimated to increase by 10.08% in next year. EPS is likely to grow at an annualized rate of 9.84% for next 5-years, compared to annual growth of 8.90% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Morgan Stanley (MS) stock as an Equal weight in their note to investors on November 15, 2024, suggesting a price target of $142 for the stock. Stock get an Underweight rating from Wells Fargo on August 02, 2024.
